Home/Filings/4/0000904454-13-000201
4//SEC Filing

Gelder Mark S. MD 4

Accession 0000904454-13-000201

CIK 0000818033other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 8:14 PM ET

Size

5.3 KB

Accession

0000904454-13-000201

Insider Transaction Report

Form 4
Period: 2013-02-08
Gelder Mark S. MD
SVP & Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-02-08+75,00075,000 total
    Exercise: $0.75Exp: 2023-02-08Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]Grant vests monthly over a 4 year period and will fully vest on February 8, 2017.

Issuer

AP PHARMA INC /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001564390

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 8:14 PM ET
Size
5.3 KB